Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Trials and tribulations of clinical trial life cycle
12 January, 2018
Dr Sanjay Sethi is a leading clinical trials manager in CPOD from...
> read more
Supply chain challenges before biosimilars 12 January, 2018 Jeff Yant, executive director of global operations at Amgen Biosimilars, discusses the challenges of producing and managing biosimilars. He talks to Sally Turner about supply...

Ensuring drug safety during clinical trials 12 January, 2018 Risk-based monitoring can promote more efficient data standardisation and speed up clinical trial timelines. Kerry Taylor-Smith speaks to Hanne Cloetta Lang, vice-president at...

Communicating clinical trial results effectively can improve public trust 12 January, 2018 Ambitious new EU guidance on transparency and disclosure aims to boost public trust, but it faces an industry-wide lack of awareness. Eleanor Wilson explores the landscape with...

Power of real-world data in clinical trials 12 January, 2018 With sophisticated technology making it more accessible than ever, real-world data has the potential to transform how clinical trials are recruited and conducted. Andrea Valentino...

Improving design of pre-clinical models for better outcome in clinical trials 12 January, 2018 The overwhelming majority of pharmaceuticals fail when tested on humans, particularly in oncology, where 95% of drugs tested in phase-I trials never make it to market. Kim Thomas...

Data control in the clinical trials cold chain 12 January, 2018 Balancing risk and cost is a delicate undertaking where controlled room temperature clinical trial shipments are concerned. Lisbeth Nielsen, senior clinical supply technician at...

Bringing together academia’s innovation and pharma’s resources 12 January, 2018 Tight budgets mean that combining the forces of academia’s innovation with pharma’s resources is happening with increasing frequency. Dr Christopher Milne, associate professor of...

Integrated data management can cut down trial cost 12 January, 2018 The digital age is upon us, yet many clinical trials are still rooted in cumbersome paper-based procedures. An integrated data management platform can reduce trial costs and times,...

Unblinded study medication for better clinical trials 12 January, 2018 Providing subjects with unblinded medication in studies and supplies is fraught with difficulty. Clinical Trials Insight examines how traditional processes cope with the challenge,...

Importance of clinical trial transparency 08 January, 2018 Trilogy Writing & Consulting’s Barry Drees and Lisa Chamberlain James explain how to communicate the results of clinical trials clearly to a lay audience, and stress the importance...

Tamper-proof barcodes to remove counterfeit drugs from supply chain 03 November, 2017 In 2019, the European Union will implement a pharmaceutical verification system mandated by the Falsified Medicines Directive (FMD); a law passed by the European Commission five...

Procurement process automation necessary for pharma firms 03 November, 2017 When it comes to bringing automation into the procurement process, pharma companies are lagging behind. In fact, many firms resist adopting the new technologies made available...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.